Three strains of a previously undescribed Actinomyces-like bacterium were isolated from human clinical sources (urine, urethra and vaginal secretion). Biochemical testing and PAGE analysis of whole-cell proteins indicated that the strains were phenotypically homogeneous and distinct from previously described Actinomyces and Arcanobacterium species. Comparative 16S rRNA gene sequencing studies showed the bacterium to be a hitherto unknown subline within a group of Actinomyces species which includes Actinomyces bovis, the type species of the genus. Based on phylogenetic and phenotypic evidence it is proposed that the unknown bacterium from humans be classified as Actinomyces urogenitalis sp. nov. The type strain of Actinomyces urogenitalis is CCUG 38702 T (l CIP 106421 T ).
The genus Actinomyces embraces a phenotypically heterogeneous group of anaerobic and facultatively anaerobic, asporogenous, Gram-positive, non-acidfast, filamentous or diphtheroidal rod-shaped organisms (Schaal, 1986) . The taxonomy of the genus Actinomyces has long been recognized as being unsatisfactory (Schaal, 1986) . During the past few years, Actinomyces taxonomy has undergone much improvement primarily driven by 16S rRNA gene sequence analysis (e.g. Pascual et al., 1997a, b ; Lawson et al., 1997) . It is now clear that the genus Actinomyces as presently defined is phylogenetically very heterogeneous and in fact encompasses several species and groups of species worthy of separate generic status. As a result, the dissection of the Actinomyces genus has commenced with the creation of the genus Actinobaculum (Lawson et al., 1997) . A second major taxonomic development has been a considerable expansion in the number of described Actinomyces and related species [e.g. Actinomyces europaeus (Funke et al., 1997) ; Actinomyces graevenitzii (Pascual et al., The GenBank accession number for the 16S rRNA gene sequence of strain CCUG 38702
T is AJ243791. 1997b) ; Actinomyces neuii subspp. anitratus and neuii (Funke et al., 1994) ; Actinomyces hyovaginalis (Collins et al., 1993) ; Actinomyces radingae (Wu$ st et al., 1995) ; Actinomyces turicensis (Wu$ st et al., 1995) ; Actinobaculum schaalii (Lawson et al., 1997) ; Arcanobacterium bernardiae (Funke et al., 1995) ; Arcanobacterium phocae (Pascual et al., 1997a) ]. The recognition of these new Actinomyces and related taxa has in the main been due to the use of phenotypic and genotypic information in concert (polyphasic taxonomy). Most of the newly described organisms have been from human sources stimulated by an increased interest in these organisms as opportunistic pathogens. In this article, we report the results of a polyphasic taxonomic study on three strains of an unusual Actinomyces-like bacterium from human clinical specimens. Based on the presented findings, yet another new species of the genus Actinomyces, Actinomyces urogenitalis, is described. cretion of a 33-year-old woman who had abnormal discharges, possibly due to the use of an intrauterine device for 7 years. Strain CCUG 42029 was recovered from human urethra (44-year-old patient). The unidentified Actinomyces-like isolates were cultured on Columbia agar (Difco) supplemented with 5 % horse blood at 37 mC, in air plus 5 % CO # . The strains were biochemically characterized by using the API rapid ID32Strep, API CORYNE and API ZYM systems according to the manufacturer's instructions (API bioMe! rieux). PAGE analysis of whole-cell proteins was performed as described by Pot et al. (1994) . For densitometric analysis, normalization and interpretation of protein patterns, the GCW 4.0 software package (Applied Maths, Kortrijk, Belgium) was used. The similarity between all pairs of traces was expressed by the Pearson product moment correlation coefficient converted for convenience to a percentage similarity. The GjC content of DNA was determined by thermal denaturation as described by Farrow et al. (1983) . The 16S rRNA genes of representative isolates were amplified by PCR and directly sequenced using a Taq DyeDeoxy Terminator Cycle sequencing kit (Applied Biosystems) and an automatic DNA sequencer (model 373A ; Applied Biosystems). The closest known relatives of the new isolates were determined by performing database searches. These sequences and those of other known related strains were retrieved from the GenBank or Ribosomal Database Project (RDP) Libraries and aligned with the newly determined sequences using the program  (Devereux et al., 1984) . The resulting multiple sequence alignment was corrected manually and a distance matrix was calculated using the programs  and  (using the Kimura-2 correction parameter) (Felsenstein, 1989) . A phylogenetic tree was constructed according to the neighbour-joining method with the program  (Felsenstein, 1989) . The stability of the groupings was estimated by bootstrap analysis (500 replications) using the programs , -,  and  (Felsenstein, 1989) . Parsimony analysis was also performed using the same package (Felsenstein, 1989) . The 16S rRNA gene sequence of strain CCUG 38702 T has been deposited in GenBank under accession number AJ243791.
The three isolates were Gram-positive straight to slightly curved rods which were non-acid-fast and nonspore-forming. The strains were catalase-negative and phenotypically closely resembled each other, producing acid from glucose, -arabitol, maltose, melibiose, melezitose, lactose, -raffinose, sucrose, trehalose and -xylose. None of the isolates produced acid from cyclodextrin, glycogen, pullulan, sorbitol or tagatose. Alanine phenylalanine proline arylamidase, α-glucosidase, β-glucosidase, α-galactosidase, β-galactosidase, β-galacturonidase, N-acetyl-β-glucosamine, pyrrolidonyl arylamidase, pyroglutamic acid arylamidase, valine arylamidase and leucine arylamidase were produced by the isolates but tests for arginine dihydrolase, acid phosphatase, chymotrypsin, esterase C-4, ester lipase C8, α-fucosidase, β-glucuronidase, glycyl tryptophane arylamidase, β-mannosidase, lipase C14, pyrazinamidase, trypsin and urease were negative. Variable reactions were observed for alkaline phosphatase, α-mannosidase and cystine arylamidase. All of the isolates hydrolysed aesculin but not gelatin or hippurate. The cellular morphology and biochemical reactions of the isolates were consistent with their assignment to the genus Actinomyces. To assess the phenotypic resemblance of the three isolates to each other and to reference Actinomyces species, a comparative analysis of whole-cell protein profiles by SDS-PAGE was performed. The three isolates clustered together and formed a distinct group with a withingroup correlation level of 85 % or more. Actinomyces slackii, Actinomyces turicensis and Actinobaculum schaalii were the nearest species to the unknown isolates, joining the cluster at a correlation level of about 60 % (Fig. 1) . The PAGE results confirmed that the three unidentified strains represent a phenotypically homogeneous group of organisms and that they are distinct from all Actinomyces species and close relatives described to date. To ascertain the phylogenetic relationships of the clinical isolates, their 16S rRNA genes were sequenced and subjected to a comparative analysis. The almost complete gene sequences ( 1500 nucleotides) of the three strains were determined and pairwise analysis showed these to be almost identical (99n8-100 % similarity). Sequence database searches confirmed the unknown bacterium was most closely related to species of the genus Actinomyces (results not shown). Highest sequence relatedness was shown with Actinomyces bovis, Actinomyces bowdenii, Actinomyces naeslundii, Actinomyces viscosus and Actinomyces slackii. The results of neighbour-joining analysis are shown in Fig. 2 and confirmed the association of the unknown clinical bacterium (as exemplified by strain CCUG 38702 T ) with Actinomyces bovis and its near relatives.
Earlier 16S rRNA sequencing studies (Pascual et al., 1997a ; Lawson et al., 1997) have shown that the genus Actinomyces is not monophyletic and consists of several lineages worthy of separate generic status. It is clear from the present 16S rRNA study that the novel bacterium reported here forms a distinct subline within a cluster of species which includes the type species Actinomyces bovis and, therefore, can be regarded as an authentic Actinomyces species. In terms of evolutionary distances, the unknown organism from clinical sources is approximately equidistant from Actinomyces bovis and Actinomyces slackii (its nearest phylogenetic relatives) and sequence divergence values of 3n3 and 3n1 % with these species, respectively, are indicative of a phylogenetically distinct species. In the treeing analysis, the association of the unidentified clinical bacterium with Actinomyces bovis was recovered in only 40 % of bootstrap replicates. The observed low bootstrap resampling value probably reflects the approximate equidistance the bacterium shows with Actinomyces bovis and Actinomyces slackii. Although there is no precise correlation between percentage 16S rRNA divergence values and species delineation, it is generally recognized that organisms displaying values close to 3 % do not belong to the same species (Stackebrandt & Goebel, 1994) . The observed 3 % sequence divergence between the unknown rod-shaped organism and Actinomyces bovis and Actinomyces slackii is consistent with this guideline. It is pertinent to note that many described genomically distinct species within the Actinobacteria display much smaller levels of sequence divergence (i.e. less than 1 or 2 %). The observed 3 % divergence between the unknown organism and other members of the Actinomyces bovis cluster of species is also very much greater than that which may be expected between different strains of the same species. Multiple strains of several Actinomyces species (and species of related genera such as Arcanobacterium and Actinobaculum) have been examined by partial and\or near complete 16S rRNA gene sequencing and levels of divergence of 0n5 % or less have invariably been found. Hence the 0n2 % divergence observed between the three unknown clinical isolates and 3 % divergence shown with respect to Actinomyces bovis and Actinomyces slackii is considered very significant. In addition to the aforementioned genetic findings, the unknown isolates are phenotypically very distinct from Actinomyces bovis, Actinomyces slackii and related species. The unknown rod-shaped bacterium differs from other species of the Actinomyces bovis cluster of organisms in numerous independent physiological and biochemical traits (see Table 1 ). Strong support for the separateness of the unknown clinical bacterium also comes from PAGE whole-cell protein profiling (Fig. 1) . It is now firmly established that this molecular chemical approach is extremely reliable for comparing closely related strains and shows excellent correlation with DNA-DNA pairing (Vandamme et al., 1996) . The PAGE protein profiling results shown in Fig. 1 unequivocally demonstrate that the unknown isolates represent a separate species from Actinomyces bovis, Actinomyces slackii and other close relatives. Therefore, based on the distinct phenotypic characteristics of the unknown rod-shaped bacterium, and the use of molecular chemical and molecular genetic evidence in concert, we are of the firm view that it merits classification as a new species of the genus Actinomyces, for which the name Actinomyces urogenitalis is proposed. Tests which are useful in differentiating Actinomyces urogenitalis from its nearest relatives are shown in Table 1 . The three isolates of Actinomyces urogenitalis were recovered from the human urogenital tract. Although the species is possibly a commensal of the human vagina, it is not known if the organism is a cause of urogenital disease. The formal description of the new species will, however, facilitate its recognition in the clinical laboratory, thereby permitting a future evaluation of any possible clinical significance.
